Trial intelligence / Profile preview

Bronchodilator versus placebo with repeated cigarette smoke inhalation in active smokers with COPD

NL-OMON33894Active, not recruiting

Sponsor
Radboud University Medical Center
Start
Sep 2009
Countries
1
01

Overview

Trial of Placebo-COD Research Private Ltd in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Pulmonary retention of cigarette smoke constituents and Cardiovascular risk biomarkers. Started Sep 2009; status: active, not recruiting.

02

Drugs

Placebo-COD Research Private Ltd
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NL-OMON33894.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33894.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call